Today announced that Navigating HEALTHCARE Reform: A Practical.

ALI-ABA’s new practical reserve on Navigating HEALTHCARE Reform The American Laws Institute-American Bar Association , the first nationwide provider of Continuing Legal Education and the industry leader in professional development for over 60 years, today announced that Navigating HEALTHCARE Reform: A Practical, Inexpensive Guide is available now. The text evaluations the individual Protection and Affordable Care Action and examines the dangers and benefits health care providers and companies will encounter in making plan changes. Shapiro, co-author of Navigating Health Care Reform. ‘The price of compliance could be significant for businesses and insurers, and it’s important that they understand the entire implications of the legislation so they can make appropriate changes.’ Related StoriesNHS ‘hourglass’ structure holds back development of support workforceBrain health: how will you reduce cognitive decline? An interview with Heather Snyder, Ph.D.Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHMENavigating HEALTHCARE Reform discusses the five major components of healthcare reform legislation, the way the federal legislation relates to existing state health care reforms, a step-by-step information to calculating medical health insurance taxes credits, how excise tax penalties are calculated, various kinds of state medical health insurance exchanges permitted under the Work and more.Greene, Ph.D., Jeffrey C. Fink, M.D., Amanda H. Anderson, Ph.D., Michael J. Choi, M.D., Jackson T. Wright, Jr., M.D., Ph.D., James P. Lash, M.D., Barry I. Freedman, M.D., Akinlolu Ojo, M.D., Ph.D., Cheryl A. Winkler, Ph.D., Dominic S. Raj, M.D., Jeffrey B. Kopp, M.D., Jiang He, M.D., Ph.D., Nancy G. Jensvold, M.P.H., Kaixiang Tao, Ph.D., Michael S. Lipkowitz, M.D., and Lawrence J. Appel, M.D., M.P.H. For the AASK and CRIC Research Investigators: APOL1 Risk Variants, Competition, and Progression of Chronic Kidney Disease In the United States, black patients have approximately twice the chance of end-stage renal disease observed among white patients, after accounting for differences in clinical and socioeconomic risk factors.1-4 This increased risk occurs despite an identical prevalence in earlier levels of chronic kidney disease5-8 in the two racial groups, which implies that kidney function declines more after the onset of chronic kidney disease in black patients rapidly.